Patents
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
12/2007
12/05/2007CN100352836C Novel depsipeptides and process for preparing same
12/05/2007CN100352835C Corn albumen powder polypeptide, its separation method and uses
12/05/2007CN100352834C Polypeptide capable of suppressing weed seed germination and rootage, and separation method and uses
12/05/2007CN100352833C Polypeptide for suppressing weed seed germination and rootage, and separation method and uses
12/05/2007CN100352832C Oligopeptides for promoting hair growing
12/04/2007US7304181 making side group protected homocysteine by reacting methionine with sodium in ammonia then alkylating the mercapto group such as with tert-butoxycarbonylalkyl protecting group; use as intermediate in synthesis cyclic peptides, particularly oxytocin antagonist peptides
12/04/2007US7304146 Detecting the phosphorylation activity of protein kinases using a substrate compound with hydrophobic moieties that integrate the compound into a micelle, non-proteinaceous fluorescent moieties (fluorescent dyes), and an enzyme recognition moiety
12/04/2007US7304129 Peptides that stimulate cell survival and axon regeneration
12/04/2007US7304128 High affinity and specificity, separation and immobilization of these structures for the fabrication of nano-devices
12/04/2007US7304036 Via controlled release of (poly)peptides which activate the guanylate cyclase C (GC-C) receptor
12/04/2007US7304035 Stimulation of bone growth with thrombin peptide derivatives
12/04/2007US7303750 Methods to improve immunogenicity of antigens and specificity of antibodies
12/04/2007CA2443929C Detection and quantification of prion isoforms in neurodegenerative diseases using mass spectrometry
12/04/2007CA2310677C In vitro and in vivo growth-promoting proteins and peptides for kidney epithelial cells
12/04/2007CA2282563C Method for the preparation of facial metal tricarbonyl compounds and their use in the labelling of biologically active substrates
12/04/2007CA2262647C Methods for regulating gastrointestinal motility
12/04/2007CA2177976C Compositions and kits for fluorescence polarization assay of large molecules
12/04/2007CA2157506C Osteogenic growth oligopeptides and pharmaceutical compositions containing them
11/2007
11/29/2007WO2007135781A1 Peptide capable of enhancing the activity of ephrin-b2, salt thereof, composition for medical purposes, kit for therapy
11/29/2007WO2007112345A3 Use of cyclosporin alkene analogues for preventing or treating viral-induced disorders
11/29/2007WO2007059076A3 Peptide-based organic sunscreens
11/29/2007WO2006107183A9 Mussel bioadhesive
11/29/2007US20070276125 Methods for inhibiting immune complex formation in a subject
11/29/2007US20070275903 oligopeptide conjugates; cleavable by trouase such as Thimet oligopeptidase; antitumor agents
11/29/2007US20070275901 Synthesis, modification and reduction of primary structure of hypotensive peptides present in scorpion venom for optimizing their use as a hypotensive medicament
11/29/2007US20070275900 HIV protease inhibitory compounds with ameliorated solubility and/or bioavailability; conjugates of therapeutic compound and a peptide wherein the conjugate is cleavable by dipeptidyl-peptidases
11/29/2007US20070275899 Treatment Of Demyelinating Autoimmune Disease with Modified Ordered Peptides
11/29/2007US20070275898 processivity clamp factor of DNA polymerase and a peptide comprising all or part of the processivity clamp factor binding sequence of a processivity clamp factor interacting protein; uses, in particular for the screening, the design or the modification of ligands
11/29/2007US20070275897 Collagen mimics
11/29/2007US20070275886 Phalloidin derivatives and methods for their synthesis
11/29/2007US20070275420 Method For Detecting Prognosis Of Cancer
11/29/2007US20070275384 Assessing human predisposition to a febrile seizure disorder
11/29/2007US20070275001 Rational Design and Engineering of Proteins and Peptides for Immunomodulation
11/29/2007DE10259834B4 Test und Screeningverfahren zur Identifizierung von Inhibitoren von Beta-Sekretasen Test and screening methods for identifying inhibitors of beta secretases
11/28/2007EP1859805A2 Peptides and peptide analogues designed from the HFE protein and their uses in the treatment of iron overload diseases
11/28/2007EP1859266A2 Compositions and methods for classifying biological samples
11/28/2007EP1858914A1 Peptide networks
11/28/2007EP0937103B1 Compounds and methods for modulating cell adhesion
11/28/2007EP0910387B1 Apoptosis associated protein bbk
11/28/2007CN101080237A Antiviral agents for the treatment, control and prevention of infections by coronaviruses
11/28/2007CN101077885A New antitumoral compounds
11/28/2007CN100351267C Human urine anti-tumor (antibacterial) peptide, its preparation and use
11/27/2007US7301041 Bi-functional metallocenes, preparation process and use in the labeling or biological molecules
11/27/2007US7300918 Method of producing vaccines from protein signal oligopeptides
11/27/2007US7300663 Adhesion and sealing of tissue with compositions containing polyfunctional crosslinking agents and protein polymers
11/27/2007CA2391333C Sustained release formulation of a peptide and a copolymer
11/25/2007CA2588344A1 Quantification of vitellogenin
11/25/2007CA2575507A1 Quantification of vitellogenin
11/22/2007WO2007133153A1 Improved antimicrobial peptides
11/22/2007WO2007133033A1 Novel analogues of antimicrobial and anticancer peptide synthesized and produced from gaegurin 5
11/22/2007WO2007097828A3 Method for identifying and validating dominant t helper cell epitopes using an hla-dm-assisted class ii binding assay
11/22/2007WO2007071448A3 Synthetic peptides for use as inhibitors of neurotransmitter secretion and as inducers of muscle relaxation
11/22/2007WO2007019532A3 Peptide aptamers that bind to the rep proteins of ssdna viruses
11/22/2007WO2007013083A3 Complement c3a derived peptides and uses thereof
11/22/2007WO2003041483A3 Method to study and mechanisms of biofilm-related antibiotic resistance
11/22/2007US20070270572 Conformational Switches in Toxin Folding and Uses Thereof
11/22/2007US20070270348 Compositions and Methods for Modulating Insulin-Activated Nitric Oxide Synthase
11/22/2007US20070269450 Biologically active peptides
11/22/2007US20070269445 Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (PRRSV), proteins encoded by the polynucleic acids, vaccines based on the proteins and/or polynucleic acids, a method of protecting a pig from a PRRSV and a method of detecting a PRRSV
11/22/2007US20070269364 Diameter-selective reversible closable peptides
11/22/2007CA2651990A1 Improved antimicrobial peptides
11/21/2007EP1857554A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor
11/21/2007EP1857553A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor
11/21/2007EP1857463A1 Peptide having neuroprotective effects
11/21/2007EP1857462A1 Polyoxyalkylene derivative
11/21/2007EP1856149A2 Cxcr3 is a gliadin receptor
11/21/2007EP1856140A1 Template-fixed beta-hairpin peptidomimetics with protease inhibitory activity
11/21/2007EP1856139A2 Compositions and methods for topical application and transdermal delivery of an oligopeptide
11/21/2007EP1269196B1 Method of screening for inhibitors of osteopontin
11/21/2007EP1200459B1 Compounds for treatment of infectious and immune system disorders and methods for their use
11/21/2007EP0842196B1 Cell adhesion inhibitors
11/21/2007EP0529031B9 Improved inhibitors of thrombin
11/21/2007EP0522091B9 Use of a mbp peptide for the preparation of a medicament for the treatment of multiple sclerosis
11/21/2007CN101076602A High-throughput enzyme-linked immuno absorbent assay (HT-ELISA) for determinaton of rho-kinase (ROK) activity
11/21/2007CN101076542A Antibodies specific for hepatocellular carcinoma and other carcinomas and uses thereof
11/21/2007CN101076516A Sulfur compounds as inhibitors of hepatitis c virus ns3 serine protease
11/21/2007CN100350050C Pseudomycin production by pseudomonas syringae
11/21/2007CN100349914C Human stomache cancer endothelial-cell specific combination short peptide series
11/20/2007US7297764 PRO4318 polypeptides
11/20/2007US7297763 Mixture of IGF-1 and N,N-bis(3-D-gluconamidopropyl)-deoxycholamine that binds specifically to IGF-1 and blocks binding of IGFBP-1 and IGFBP-3; used as a standard for identifying IGF-1 indirect agonists
11/20/2007US7297762 Avian pancreatic polypeptide/scaffold; phage display libraries
11/20/2007US7297759 Peptides for increasing transfection efficiency
11/20/2007CA2229544C Cyclic peptide analogs of somatostatin
11/20/2007CA2192455C Positive and positive/negative cell selection mediated by peptide release
11/15/2007WO2007129999A2 Antiproliferative peptides and antibodies for their detection
11/15/2007WO2007129077A2 Imaging agent
11/15/2007WO2007128796A1 Peptides for use in diagnosing the presence of ruptured atherosclerotic lesions in an individual
11/15/2007WO2007128553A2 Mig12
11/15/2007WO2007128493A1 Neuroprotective compounds and uses thereof
11/15/2007WO2007087758A3 Mimotopes of capsular polysaccharides of neisseria meningitidis and pharmaceutical formulations
11/15/2007WO2007084002A3 Antibiotics and methods for producing them.
11/15/2007WO2007076501A3 Endometriosis cell targeting peptide and uses thereof
11/15/2007WO2004058988A3 Binding agents which inhibit myostatin
11/15/2007WO2002068586A3 Hiv/fiv protease inhibitors
11/15/2007US20070265206 Cyclic Natriuretic Peptide Constructs
11/15/2007US20070265201 Inhibitors of inflammatory cytokine transcription derived from hcmv protein ie2
11/15/2007US20070264689 Ztnfr12 polypeptides and Ztnfr12 fusion proteins
11/15/2007US20070264234 Cytokine Variant Polypeptides
11/15/2007US20070264194 Peptides That Bind To Atherosclerotic Lesions
11/15/2007US20070264191 Materials and Methods Relating to the Treatment of Glioblastomas